Solvias Opens 50,000 Sq. Ft. Center of Excellence for Biologics in RTP

  • Solvias has opened a 50,000-square-foot Center of Excellence for Biologics and Cell and Gene Therapy in Research Triangle Park, North Carolina.
  • The facility, rolled out in two phases, will create approximately 200 jobs and provide GMP analytical services for biologics development and commercialization.

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, has launched its Center of Excellence for Biologics and Cell and Gene Therapy in Research Triangle Park (RTP), North Carolina. The new facility expands the company’s global footprint and aims to accelerate the development of transformative therapies for cancer and rare diseases.

Spanning 50,000 square feet, the RTP site is Solvias’ flagship North American facility for large molecule analytical services. It is being introduced in two phases: a 20,000-square-foot cGMP release testing laboratory, now operational, and an additional 30,000 square feet set to open in July 2025, offering expanded capabilities for stability testing and advanced biophysical characterization.

Equipped with state-of-the-art instrumentation, laboratory automation, and digital management systems, the center will support GMP testing for monoclonal antibodies (mAbs), cell and gene therapies, and other biologics from preclinical stages through to commercial release.

“This Center of Excellence in RTP is a milestone in Solvias’ global growth journey,” said Archie Cullen, Chief Executive Officer of Solvias. “Combining our team’s expertise with advanced technology, we aim to set a new benchmark for delivering high-quality, reliable analytical support. It’s an honor to partner with our clients in bringing groundbreaking therapies to patients worldwide.”

“We are focused on helping our clients succeed with our analytical expertise. We are hiring the best possible talent to be technical partners for our clients, helping them bring therapies to market faster and more efficiently. With this investment, we are committed to be an integral part of the US biopharma innovation ecosystem,” said Ilya Koltover, Chief Commercial Officer of Solvias. 

Experience the future of contract manufacturing

Join us at CDMO Live, 7-8 May 2025 in Rotterdam for an exclusive live event dedicated to contract manufacturing partnerships. Apply for your ticket.

Sign up to our free weekly newsletter for all the latest contract manufacturing news.  Register here

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.